SCOPUS 정보 검색 플랫폼

American Journal of Health-System Pharmacy

Volumn 58, Issue 15, 2001, Pages 1432-1436

Comparison of eptifibatide and abciximab with decision analysis

(1) Wong, D H a

a Methodist Hospital California (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE;

ARTICLE; BLEEDING; BRADYCARDIA; COST BENEFIT ANALYSIS; DECISION MAKING; DRUG APPROVAL; DRUG EFFECT; DRUG EFFICACY; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035426432 PISSN: 10792082 EISSN: None Source Type: Journal
DOI: 10.1093/ajhp/58.15.1432 Document Type: Article

Times cited : (7)

References (15)

1
- 2242477091
- Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in high-risk coronary angioplasty
- (1994) N Engl J Med , vol.330 , pp. 956-961

2
- 1842369101
- Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
- (1997) N Engl J Med , vol.336 , pp. 1689-1696

3
- 0030919511
- Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II
- (1997) Lancet , vol.349 , pp. 1422-1428

4
- 0008926519
- Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
- (1998) N Engl J Med , vol.339 , pp. 436-443

5
- 0030918995
- Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
- (1997) Lancet , vol.349 , pp. 1429-1435

6
- 0032508297
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
- (1998) Lancet , vol.352 , pp. 87-92

7
- 0028811436
- Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention
- (1995) Am J Cardiol , vol.76 , pp. 1222-1227
- Huntington, R.A.¹ Kleiman, N.S.² Kottke-Marchant, D.³

8
- 0003704731
- Indianapolis, IN: Eli Lilly
- (1998) ReoPro package insert

9
- 4244122429
- San Francisco, CA: COR Therapeutics
- (1998) Integrilin package insert

10
- 9544243719
- Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty
- (1996) Circulation , vol.94 , pp. 629-635
- Mark, D.B.¹ Talley, J.D.² Topol, E.J.³

11
- 0031750340
- Cost-effectiveness analysis of abciximab: A Canadian hospital perspective
- (1998) Ann Pharmacother , vol.32 , pp. 536-542
- Zed, P.J.¹ Frighetto, L.² Sunderji, R.³

12
- 0032877309
- Analysis of number needed to treat and cost of platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary interventions and acute coronary syndromes
- (1999) Pharmacotherapy , vol.19 , pp. 1086-1093
- Bell, D.M.¹

13
- 0033015472
- Using decision analysis to evaluate the cost-effectiveness of GP IIb/IIIa antagonists
- (1999) Formulary , vol.34 , pp. 515-522
- Cox, C.R.¹

14
- 0034676781
- Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): A randomised, placebo-controlled trial
- (2000) Lancet , vol.356 , pp. 2037-2044

15
- 0023258694
- Thrombolysis in Myocardial Infarction (TIMI) trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase
- (1987) Circulation , vol.76 , pp. 142-154
- Chesebro, J.H.¹ Knatterud, G.² Roberts, R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.